var data={"title":"Approach to the adult with lymphocytosis or lymphocytopenia","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Approach to the adult with lymphocytosis or lymphocytopenia</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/contributors\" class=\"contributor contributor_credentials\">Matthew S Davids, MD, MMSc</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/contributors\" class=\"contributor contributor_credentials\">Stanley L Schrier, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/contributors\" class=\"contributor contributor_credentials\">Alan G Rosmarin, MD</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Feb 05, 2018.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H330922311\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Lymphocytosis refers to an increase of peripheral blood lymphocytes, which for adults corresponds to &gt;4000 <span class=\"nowrap\">lymphocytes/microL</span> in most clinical laboratories.</p><p>Lymphocytopenia refers to a decrease of peripheral blood lymphocytes, which generally corresponds to &lt;1000 <span class=\"nowrap\">lymphocytes/microL</span> in adults.</p><p>This topic discusses the causes and our approach to clinical evaluation of lymphocytosis and lymphocytopenia in adults. The evaluation and causes of leukocytosis and lymphocytopenia in children are discussed separately. (See <a href=\"topic.htm?path=approach-to-the-child-with-lymphocytosis-or-lymphocytopenia\" class=\"medical medical_review\">&quot;Approach to the child with lymphocytosis or lymphocytopenia&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H1891381287\"><span class=\"h1\">DEFINITIONS AND NORMAL VALUES</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The normal range (ie, two standard deviations above and below the mean) for the white blood cell (WBC) count in adults is 4400 to 11,000 <span class=\"nowrap\">cells/microL</span> in most clinical laboratories. Lymphocytes generally constitute 8 to 33 percent of WBCs in peripheral blood.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Absolute lymphocyte count</strong> &ndash; The absolute lymphocyte count (ALC) is used to quantitate lymphocytes in peripheral blood (rather than the percentage of lymphocytes in the WBC differential count).</p><p/><p class=\"bulletIndent1\">ALC is calculated as follows:</p><p/><div class=\"formulaContainer\"><div class=\"formula\"><p class=\"bulletIndent2\">ALC <span class=\"nowrap\">(cells/microL)</span> = WBC <span class=\"nowrap\">(cells/microL)</span> x percent lymphocytes &divide; 100</p></div></div><p/><p class=\"bulletIndent1\">Normal values for ALC generally correspond to 1000 to 4000 <span class=\"nowrap\">lymphocytes/microL,</span> but may vary in different laboratories.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Lymphocytosis</strong> corresponds to ALC &gt;4000 <span class=\"nowrap\">cells/microL</span> for adults.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Lymphocytopenia</strong> corresponds to ALC &lt;1000 <span class=\"nowrap\">cells/microL</span> for adults.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Lymphocyte subsets</strong> &ndash; Normal proportions of T lymphocytes, B lymphocytes, and natural killer (NK) cells in the peripheral blood are:</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>T cells (CD3+) &ndash; 60 to 80 percent</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>B cells (CD20+) &ndash; 10 to 20 percent</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>NK cells (CD56+) &ndash; 5 to 10 percent</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>T lymphocyte subtypes</strong> &ndash; Normal proportions of T cell subtypes in peripheral blood are:</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span><span class=\"nowrap\">Helper/inducer</span> T cells (CD4+) &ndash; 60 to 70 percent</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span><span class=\"nowrap\">Suppressor/cytotoxic</span> T cells (CD8+) &ndash; 30 to 40 percent</p><p/><p class=\"bulletIndent1\">Normal values for WBC and lymphocyte counts in children vary by age and are discussed separately. (See <a href=\"topic.htm?path=approach-to-the-child-with-lymphocytosis-or-lymphocytopenia\" class=\"medical medical_review\">&quot;Approach to the child with lymphocytosis or lymphocytopenia&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H1031225720\"><span class=\"h1\">MECHANISMS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Lymphocyte differentiation and maturation are life-long processes that take place in the bone marrow and secondary lymphoid organs (eg, lymph nodes, spleen, thymus). Details of lymphocyte development are discussed separately. (See <a href=\"topic.htm?path=normal-b-and-t-lymphocyte-development\" class=\"medical medical_review\">&quot;Normal B and T lymphocyte development&quot;</a>.)</p><p>Lymphocytosis may be caused by increased production, redistribution (from bone marrow <span class=\"nowrap\">and/or</span> secondary lymphoid organs), <span class=\"nowrap\">and/or</span> decreased cell death (eg, from impaired apoptosis in some lymphoproliferative disorders). Various causes of lymphocytosis differ in the contribution from each of these mechanisms.</p><p>Increased lymphocyte production may be due to a malignant process or in response to an infectious or inflammatory stimulus. Malignant lymphocytosis involves expansion of a clone of related cells, whereas reactive processes generally reflect polyclonal expansion of lymphocytes. Reactive processes may lead to expansion of one or more subsets of lymphocytes (ie, T cells, B cells, <span class=\"nowrap\">and/or</span> NK cells).</p><p class=\"headingAnchor\" id=\"H2705667192\"><span class=\"h1\">CAUSES OF LYMPHOCYTOSIS</span></p><p class=\"headingAnchor\" id=\"H1692569306\"><span class=\"h2\">Infectious causes</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Specific infectious causes of reactive lymphocytosis vary depending on demographic characteristics of the population. As examples, the incidence of certain infections varies based on geography, and infectious mononucleosis is more common in young adults.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Infectious mononucleosis</strong> (IM) is a viral infection characterized by fever, tonsillar pharyngitis, and lymphadenopathy. Lymphocytosis is the most common hematologic manifestation of IM, and lymphocytes may constitute more than half of circulating leukocytes. The peripheral blood smear usually contains reactive &quot;atypical&quot; lymphocytes (<a href=\"image.htm?imageKey=HEME%2F55986\" class=\"graphic graphic_picture graphicRef55986 \">picture 1</a>) that peak during the second and third week of illness and may persist for up to two months [<a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/1\" class=\"abstract_t\">1</a>]. (See <a href=\"#H4177589950\" class=\"local\">'Peripheral blood smear'</a> below.)</p><p/><p class=\"bulletIndent1\">IM is most often caused by infection with Epstein-Barr virus (EBV). IM may also be associated with other hematologic findings, including hemolytic anemia and thrombocytopenia. (See <a href=\"topic.htm?path=infectious-mononucleosis-in-adults-and-adolescents#H15\" class=\"medical medical_review\">&quot;Infectious mononucleosis in adults and adolescents&quot;, section on 'Hematologic abnormalities'</a>.)</p><p/><p class=\"bulletIndent1\">Other infectious agents can cause a nearly indistinguishable IM syndrome including cytomegalovirus (CMV), human immunodeficiency virus (HIV), other viruses, and toxoplasmosis. (See <a href=\"topic.htm?path=infectious-mononucleosis-in-adults-and-adolescents#H29\" class=\"medical medical_review\">&quot;Infectious mononucleosis in adults and adolescents&quot;, section on 'EBV-negative mononucleosis'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Other viral illnesses</strong> that can be associated with lymphocytosis include:</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>HIV</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>HTLV-I (human T-lymphotropic virus type I)</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>CMV</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Mumps</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Rubella</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Measles</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Influenza</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Hepatitis</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Adenovirus</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Coxsackie virus</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Poliovirus</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Pertussis</strong> &ndash; Pertussis (whooping cough) is a respiratory infection caused by <em>Bordetella pertussis </em>infection. Unlike most other acute bacterial infections, pertussis commonly causes lymphocytosis. The lymphocytes in pertussis often have a characteristic appearance with a convoluted <span class=\"nowrap\">and/or</span> cleaved nucleus (<a href=\"image.htm?imageKey=HEME%2F115806\" class=\"graphic graphic_picture graphicRef115806 \">picture 2</a>). Clinical manifestations and diagnosis of pertussis are described separately. (See <a href=\"topic.htm?path=pertussis-infection-in-adolescents-and-adults-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Pertussis infection in adolescents and adults: Clinical manifestations and diagnosis&quot;</a>.)</p><p/><p class=\"bulletIndent1\">Lymphocytosis appears to be specific to <em>B. pertussis </em>infection, since it is not seen with a clinically identical illness caused by <em>B. parapertussis</em>. As an example, in one study of 114 patients the mean absolute lymphocyte count (ALC) was significantly lower in those infected with <em>B. parapertussis</em> than in those with <em>B. pertussis</em> (3500 versus <span class=\"nowrap\">7800/microL,</span> respectively) [<a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/2\" class=\"abstract_t\">2</a>]. Because both <em>B. pertussis</em> and <em>B. parapertussis</em> express pertussis toxin, some other effect of <em>B. pertussis</em> must account for the lymphocytosis.</p><p/><p class=\"bulletIndent1\">The lymphocytosis in pertussis is polyclonal with a normal T:B lymphocyte ratio and appears to be due to a block in extravasation of lymphocytes from the blood into lymph nodes, rather than an increase in lymphocyte production [<a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/3\" class=\"abstract_t\">3</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Cat scratch disease </strong>&ndash; Cat scratch disease is an infection with <em>Bartonella henselae </em>that manifests as lymphadenopathy and can be associated with neurologic, ocular, and other organ involvement. The lymphocytosis usually includes large atypical lymphocytes and may be accompanied by mild eosinophilia, monocytosis, anemia, <span class=\"nowrap\">and/or</span> thrombocytopenia [<a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/4\" class=\"abstract_t\">4</a>]. Details of the clinical presentation and diagnosis of cat scratch disease are discussed separately. (See <a href=\"topic.htm?path=microbiology-epidemiology-clinical-manifestations-and-diagnosis-of-cat-scratch-disease\" class=\"medical medical_review\">&quot;Microbiology, epidemiology, clinical manifestations, and diagnosis of cat scratch disease&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Other infectious causes </strong>&ndash; Infections such as tuberculosis, brucellosis, syphilis, babesiosis, and rickettsial infections may present a similar hematologic picture. </p><p/><p class=\"headingAnchor\" id=\"H3707269253\"><span class=\"h2\">Non-infectious causes</span></p><p class=\"headingAnchor\" id=\"H1443801887\"><span class=\"h3\">Drug hypersensitivity reactions</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Drug reaction with eosinophilia and systemic symptoms (DRESS) is an <span class=\"nowrap\">allergic/hypersensitivity</span> reaction to a medication or acute serum sickness. DRESS usually occurs two to six weeks after starting the offending drug. Lymphocytosis with atypical lymphocytes and eosinophilia is seen in 30 to 70 percent of cases of DRESS. Additional details are presented separately (<a href=\"image.htm?imageKey=DERM%2F86760\" class=\"graphic graphic_table graphicRef86760 \">table 1</a>). (See <a href=\"topic.htm?path=drug-reaction-with-eosinophilia-and-systemic-symptoms-dress\" class=\"medical medical_review\">&quot;Drug reaction with eosinophilia and systemic symptoms (DRESS)&quot;</a> and <a href=\"topic.htm?path=drug-allergy-classification-and-clinical-features\" class=\"medical medical_review\">&quot;Drug allergy: Classification and clinical features&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H1909659640\"><span class=\"h3\">Stress</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Lymphocytosis can be associated with severe medical stress, including trauma, cardiac emergencies, or status epilepticus. A study of 73 adults (age 43 to 93 years) with such conditions reported ALCs from 4000 to <span class=\"nowrap\">13,000/microL</span> that was often followed by neutrophilia [<a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/5\" class=\"abstract_t\">5</a>]. Lymphocytosis in this setting has been associated with mortality rates of 25 to 50 percent [<a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/5,6\" class=\"abstract_t\">5,6</a>].</p><p class=\"headingAnchor\" id=\"H3698562569\"><span class=\"h3\">Persistent polyclonal B cell lymphocytosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A syndrome of persistent polyclonal B cell lymphocytosis (PPBL) has been described in young to middle-aged women who smoke cigarettes. The syndrome includes polyclonal B cell expansion, a polyclonal increase in serum IgM, and may be accompanied by splenomegaly <span class=\"nowrap\">and/or</span> lymphadenopathy [<a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/7-11\" class=\"abstract_t\">7-11</a>]. The median ALC is 5500 <span class=\"nowrap\">cells/microL</span> (range 2000 to 21,000 <span class=\"nowrap\">cells/microL)</span> with characteristic binucleate lymphocytes (<a href=\"image.htm?imageKey=HEME%2F116325\" class=\"graphic graphic_picture graphicRef116325 \">picture 3</a>).</p><p>Despite the presence of cytogenetic anomalies in most patients (eg, isochromosome 3q, <em><span class=\"nowrap\">BCL2/</em>immunoglobulin</span> gene rearrangements), the clinical course typically remains stable for years. As an example, a study of more than 100 patients reported 89 percent four-year event-free survival [<a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/12,13\" class=\"abstract_t\">12,13</a>]. </p><p>The pathogenesis of PPBL is not known. Potential mechanisms include a defect in the CD40 activation pathway, expansion of functional IgD+ CD27+ memory B cells, or undefined genetic defects [<a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/14-18\" class=\"abstract_t\">14-18</a>]. </p><p class=\"headingAnchor\" id=\"H992688327\"><span class=\"h3\">Asplenia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Moderate levels of polyclonal lymphocytosis are common after splenectomy. Most patients with post-splenectomy lymphocytosis have large granular lymphocytes on the peripheral smear and expansion of NK cells [<a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/19,20\" class=\"abstract_t\">19,20</a>]. In one series, 20 of 23 patients who underwent splenectomy (most for Hodgkin lymphoma) had lymphocyte counts from 4000 to <span class=\"nowrap\">8700/microL;</span> lymphocytosis persisted almost unchanged with median follow-up of more than four years [<a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/19\" class=\"abstract_t\">19</a>].</p><p class=\"headingAnchor\" id=\"H219026063\"><span class=\"h3\">Thymoma</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Thymoma is a thymic malignancy that typically affects middle-aged adults and may be associated with paraneoplastic autoimmune syndromes (eg, myasthenia gravis, pure red cell aplasia). Thymoma is occasionally associated with polyclonal T cell lymphocytosis that resolves following successful treatment of the tumor [<a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/21-24\" class=\"abstract_t\">21-24</a>]. The cause of the lymphocytosis is unclear, but the circulating lymphocytes appear normal by morphology, immunophenotyping, and T cell receptor gene rearrangement studies [<a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/22\" class=\"abstract_t\">22</a>]. Further description of clinical aspects of thymoma is provided separately. (See <a href=\"topic.htm?path=clinical-presentation-and-management-of-thymoma-and-thymic-carcinoma\" class=\"medical medical_review\">&quot;Clinical presentation and management of thymoma and thymic carcinoma&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H1516036561\"><span class=\"h2\">Clonal processes</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Causes of clonal lymphocytosis exist on a spectrum and range from premalignant disorders (that may later evolve to overt malignancies) to a variety of lymphomas and leukemias.</p><p class=\"headingAnchor\" id=\"H1359939611\"><span class=\"h3\">Monoclonal B lymphocytosis</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Definition and epidemiology</strong> &ndash; Monoclonal B cell lymphocytosis (MBL) refers to a monoclonal population of B lymphocytes &lt;5000 <span class=\"nowrap\">cells/microL</span> in peripheral blood (ie, below the threshold for diagnosis of chronic lymphocytic leukemia [CLL]), without associated clinical findings of an autoimmune condition, infectious disease, or lymphoproliferative disorder [<a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/25-30\" class=\"abstract_t\">25-30</a>]. B cell clonality may be detected in some individuals with &lt;4000 <span class=\"nowrap\">lymphocytes/microL</span> (ie, the threshold for defining lymphocytosis) [<a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/29,31,32\" class=\"abstract_t\">29,31,32</a>].</p><p/><p class=\"bulletIndent1\">Most patients have monoclonal B cells with an immunophenotype that is indistinguishable from CLL, while other cases have a non-CLL-like immunophenotype; it is unclear if this distinction has prognostic significance [<a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/32\" class=\"abstract_t\">32</a>].</p><p/><p class=\"bulletIndent1\">Estimated prevalence of MBL varies depending on the detection method and the population studied [<a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/25,33\" class=\"abstract_t\">25,33</a>]. An international consortium reported MBL in 2 to 3 percent of the overall population, but &gt;5 percent in people over 60 years of age [<a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/32\" class=\"abstract_t\">32</a>]. A review of more than 2000 blood donors &ge;45 years old reported MBL in 7 percent [<a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/34\" class=\"abstract_t\">34</a>]. The prevalence of MBL is increased in relatives of patients with CLL. (See <a href=\"topic.htm?path=clinical-presentation-pathologic-features-diagnosis-and-differential-diagnosis-of-chronic-lymphocytic-leukemia#H602942821\" class=\"medical medical_review\">&quot;Clinical presentation, pathologic features, diagnosis, and differential diagnosis of chronic lymphocytic leukemia&quot;, section on 'Family studies'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Evaluation and diagnosis of MBL </strong>&ndash;<strong> </strong>MBL is usually diagnosed after an incidental finding of lymphocytosis on complete blood count (CBC). The patient with MBL should be evaluated by history and physical examination, CBC and differential count, review of the blood smear, and immunophenotype by flow cytometry.</p><p/><p class=\"bulletIndent1\">Diagnostic criteria for MBL include the following (<a href=\"image.htm?imageKey=HEME%2F103750\" class=\"graphic graphic_table graphicRef103750 \">table 2</a>) [<a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/32\" class=\"abstract_t\">32</a>]: </p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Monoclonal population of B cells &lt;5000 <span class=\"nowrap\">cells/microL</span> that persists for &ge;3 months</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Monoclonality documented by immunoglobulin (Ig) heavy chain rearrangement or light chain restriction (eg, kappa:lambda ratio &gt;3:1 or &lt;0.3:1)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>No systemic features of a lymphoproliferative disorder (eg, no lymphadenopathy, hepatosplenomegaly, fever, weight loss, or sweats)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>No autoimmune or infectious disease </p><p/><p class=\"bulletIndent1\">Immunophenotype reveals one of the following patterns:</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>CLL-like: CD5+, CD19+, CD23+; weak expression of CD20; light chain restriction with low surface Ig expression.</p><p/><p class=\"bulletIndent3\">Individuals with CLL-like MBL do not require evaluation beyond physical examination, CBC, and immunophenotype.</p><p/><p class=\"bulletIndent3\">Patients with CLL-like MBL together with lymphadenopathy <span class=\"nowrap\">and/or</span> hepatosplenomegaly are generally diagnosed as having small lymphocytic lymphoma (SLL). Further details of SLL are provided separately. (See <a href=\"topic.htm?path=clinical-manifestations-pathologic-features-and-diagnosis-of-small-lymphocytic-lymphoma\" class=\"medical medical_review\">&quot;Clinical manifestations, pathologic features, and diagnosis of small lymphocytic lymphoma&quot;</a>.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Atypical (non-CLL-like): CD5 negative, CD20+, light chain restriction with <span class=\"nowrap\">moderate/strong</span> surface Ig expression.</p><p/><p class=\"bulletIndent3\">Patients with atypical MBL should be evaluated to exclude an underlying non-Hodgkin lymphoma (NHL). Evaluation should include bone marrow examination, fluorescence in situ hybridization (FISH) for t(11;14) translocation (to exclude mantle cell lymphoma), and radiologic imaging [<a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/25\" class=\"abstract_t\">25</a>]. Further details regarding diagnosis of NHL are provided separately. (See <a href=\"topic.htm?path=clinical-presentation-and-diagnosis-of-non-hodgkin-lymphoma\" class=\"medical medical_review\">&quot;Clinical presentation and diagnosis of non-Hodgkin lymphoma&quot;</a>.) </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Monitoring</strong> &ndash; Individuals with MBL should be monitored for progression to CLL or other lymphoid malignancy.</p><p/><p class=\"bulletIndent1\">Interval history, physical examination, and CBC with differential count should be performed twice a year for the first two years; if clinically stable, the interval can be extended to every one to two years for the remainder of the patient's life. Patients should report lymphadenopathy or B symptoms (eg, fever, sweats, weight loss), but unless the clinical condition changes, there is no need for routine imaging studies, bone marrow examination, or repeat flow cytometry.</p><p/><p class=\"bulletIndent1\">If the ALC rises to <span class=\"nowrap\">&gt;5000/microL,</span> management should be that of CLL, which is discussed separately. (See <a href=\"topic.htm?path=clinical-presentation-pathologic-features-diagnosis-and-differential-diagnosis-of-chronic-lymphocytic-leukemia\" class=\"medical medical_review\">&quot;Clinical presentation, pathologic features, diagnosis, and differential diagnosis of chronic lymphocytic leukemia&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Progression to CLL</strong> &ndash; The rate of progression of MBL to CLL has been estimated at about 1 percent per year and it does not plateau [<a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/29,35\" class=\"abstract_t\">29,35</a>]. Although most patients with CLL likely had antecedent MBL, most people with MBL will not develop CLL.</p><p/><p class=\"bulletIndent1\">As an example, a study of 185 individuals with CLL-like MBL reported that 15 percent developed progressive CLL with a median follow up of 6.7 years [<a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/29\" class=\"abstract_t\">29</a>]. Symptomatic disease that required chemotherapy developed at a rate of 1.1 percent per year. The level of initial ALC was independently associated with progression of lymphocytosis.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong><span class=\"nowrap\">Blood/stem</span> cell donation</strong> &ndash; There is no consensus about whether a patient with MBL is a suitable donor of blood or stem cells (for hematopoietic cell transplantation [HCT]) [<a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/30\" class=\"abstract_t\">30</a>]. In the United States, there is no national policy about either issue; a decision regarding donor suitability is at the discretion of each center's medical director <span class=\"nowrap\">and/or</span> transplantation physician (for allogeneic HCT).</p><p/><p class=\"bulletIndent1\">Although there are reports of transmission of <span class=\"nowrap\">MBL/CLL</span> to recipients of stem cells [<a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/36-38\" class=\"abstract_t\">36-38</a>], selection of stem cell donors must balance various factors, as described separately. (See <a href=\"topic.htm?path=donor-selection-for-hematopoietic-cell-transplantation#H91588355\" class=\"medical medical_review\">&quot;Donor selection for hematopoietic cell transplantation&quot;, section on 'General approach'</a>.)</p><p/><p class=\"bulletIndent1\">There are no reports of transmission of MBL or CLL by blood transfusion. </p><p/><p class=\"headingAnchor\" id=\"H1951432233\"><span class=\"h3\">Congenital B cell lymphocytosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Congenital B cell lymphocytosis is a rare familial syndrome in which infants present with splenomegaly and polyclonal expansion of B cells that progresses to CLL by the fourth decade of life [<a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/39\" class=\"abstract_t\">39</a>].</p><p>Affected patients have mutations of <em>CARD11</em>, which encodes a protein (caspase recruitment domain-containing protein 11) required for nuclear factor-kappa B activation of B and T lymphocytes. The role of CARD11 in lymphocyte function is described separately. (See <a href=\"topic.htm?path=combined-immunodeficiencies#H2235550\" class=\"medical medical_review\">&quot;Combined immunodeficiencies&quot;, section on 'Caspase recruitment domain-containing protein 11 deficiency'</a>.)</p><p class=\"headingAnchor\" id=\"H2679685677\"><span class=\"h3\">Large granular lymphocyte leukemia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Large granular lymphocyte (LGL) leukemia is characterized by infiltration of peripheral blood and bone marrow by clonal LGLs, splenomegaly, and cytopenias (usually neutropenia). Patients typically present in the fourth or fifth decade of life with autoimmune manifestations and neutropenia. The blood smear characteristically reveals large lymphocytes with slightly eccentric nuclei, abundant pale-blue cytoplasm, and azurophilic granules (<a href=\"image.htm?imageKey=HEME%2F69027\" class=\"graphic graphic_picture graphicRef69027 \">picture 4</a>) at levels &gt;2000 <span class=\"nowrap\">cells/microL;</span> some patients have a normal ALC with an increased percentage of cytotoxic (CD8+) lymphocytes [<a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/40-42\" class=\"abstract_t\">40-42</a>].</p><p>Details of the clinical presentation and diagnosis of LGL leukemia are discussed separately. (See <a href=\"topic.htm?path=natural-killer-nk-cell-large-granular-lymphocyte-leukemia\" class=\"medical medical_review\">&quot;Natural killer (NK) cell large granular lymphocyte leukemia&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H1616252797\"><span class=\"h3\">Chronic lymphocytic leukemia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Chronic lymphocytic leukemia (CLL) is a chronic lymphoproliferative neoplasm characterized by progressive accumulation in peripheral blood and bone marrow of lymphocytes that may be accompanied by lymphadenopathy, splenomegaly, <span class=\"nowrap\">and/or</span> constitutional symptoms. CLL is defined by the presence of &ge;5000 <span class=\"nowrap\">lymphocytes/microL</span>. The leukemic cells are typically small and mature-appearing with a dense nucleus, partially clumped chromatin, no discernible nucleoli, and a thin border of clear or slightly basophilic cytoplasm. Some of the lymphocytes may be larger with a notched nucleus, lacy-appearing chromatin, and prominent visible nucleoli (so-called prolymphocytes). The smear typically contains characteristic &quot;smudge&quot; cells that appear to have been damaged when smeared on a glass slide (<a href=\"image.htm?imageKey=HEME%2F96498\" class=\"graphic graphic_picture graphicRef96498 \">picture 5</a>).</p><p>Clinical manifestations, pathologic features, and diagnosis of CLL are discussed in detail separately. (See <a href=\"topic.htm?path=clinical-presentation-pathologic-features-diagnosis-and-differential-diagnosis-of-chronic-lymphocytic-leukemia\" class=\"medical medical_review\">&quot;Clinical presentation, pathologic features, diagnosis, and differential diagnosis of chronic lymphocytic leukemia&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H3993973188\"><span class=\"h3\">Non-Hodgkin lymphoma</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Most categories of non-Hodgkin lymphoma (NHL) can be associated with lymphocytosis, but certain subtypes are more likely:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>S&eacute;zary syndrome</strong>, which is defined by the presence of circulating malignant T lymphocytes; details of clinical manifestations and diagnosis are presented separately. (See <a href=\"topic.htm?path=clinical-presentation-pathologic-features-and-diagnosis-of-sezary-syndrome\" class=\"medical medical_review\">&quot;Clinical presentation, pathologic features, and diagnosis of S&eacute;zary syndrome&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Mantle cell lymphoma</strong> (MCL) has the highest prevalence of lymphocytosis among B cell lymphomas; about one half of patients with MCL have lymphocytosis. Additional details are presented separately. (See <a href=\"topic.htm?path=clinical-manifestations-pathologic-features-and-diagnosis-of-mantle-cell-lymphoma\" class=\"medical medical_review\">&quot;Clinical manifestations, pathologic features, and diagnosis of mantle cell lymphoma&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Follicular lymphoma </strong>and<strong> splenic marginal zone lymphoma </strong>are often associated with lymphocytosis. (See <a href=\"topic.htm?path=clinical-manifestations-pathologic-features-diagnosis-and-prognosis-of-follicular-lymphoma\" class=\"medical medical_review\">&quot;Clinical manifestations, pathologic features, diagnosis, and prognosis of follicular lymphoma&quot;</a> and <a href=\"topic.htm?path=splenic-marginal-zone-lymphoma\" class=\"medical medical_review\">&quot;Splenic marginal zone lymphoma&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Subtypes of NHL less commonly associated with lymphocytosis include diffuse large B cell lymphoma, Burkitt lymphoma, and T cell lymphoma other than S&eacute;zary syndrome. (See <a href=\"topic.htm?path=epidemiology-clinical-manifestations-pathologic-features-and-diagnosis-of-diffuse-large-b-cell-lymphoma\" class=\"medical medical_review\">&quot;Epidemiology, clinical manifestations, pathologic features, and diagnosis of diffuse large B cell lymphoma&quot;</a> and <a href=\"topic.htm?path=epidemiology-clinical-manifestations-pathologic-features-and-diagnosis-of-burkitt-lymphoma\" class=\"medical medical_review\">&quot;Epidemiology, clinical manifestations, pathologic features, and diagnosis of Burkitt lymphoma&quot;</a> and <a href=\"topic.htm?path=clinical-manifestations-pathologic-features-and-diagnosis-of-peripheral-t-cell-lymphoma-not-otherwise-specified\" class=\"medical medical_review\">&quot;Clinical manifestations, pathologic features, and diagnosis of peripheral T cell lymphoma, not otherwise specified&quot;</a>.)</p><p/><p>The morphologic appearance and immunophenotype of circulating lymphocytes depends on the subtype of underlying NHL.</p><p class=\"headingAnchor\" id=\"H2376257218\"><span class=\"h3\">Acute lymphoblastic leukemia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Acute lymphoblastic leukemia (ALL) may be derived from T, B, or NK cells, and can present at any age. Lymphoblasts vary from small cells with scant cytoplasm, condensed nuclear chromatin, and indistinct nucleoli to larger cells with moderate amounts of cytoplasm, dispersed chromatin, and multiple nucleoli; a few azurophilic cytoplasmic granules may be present (<a href=\"image.htm?imageKey=HEME%2F65474\" class=\"graphic graphic_picture graphicRef65474 \">picture 6</a>). Typical presenting symptoms are nonspecific and may include symptoms of cytopenias, fever, bone pain, lymphadenopathy, organomegaly, <span class=\"nowrap\">and/or</span> mediastinal mass. The immunophenotype varies depending on the lineage of the leukemic cells (eg, B versus T lineage).</p><p>Details of the clinical presentation and diagnosis of B cell ALL and T cell <span class=\"nowrap\">leukemia/lymphoma</span> in adults are discussed separately (See <a href=\"topic.htm?path=clinical-manifestations-pathologic-features-and-diagnosis-of-precursor-b-cell-acute-lymphoblastic-leukemia-lymphoma\" class=\"medical medical_review\">&quot;Clinical manifestations, pathologic features, and diagnosis of precursor B cell acute lymphoblastic leukemia/lymphoma&quot;</a> and <a href=\"topic.htm?path=clinical-manifestations-pathologic-features-and-diagnosis-of-precursor-t-cell-acute-lymphoblastic-leukemia-lymphoma\" class=\"medical medical_review\">&quot;Clinical manifestations, pathologic features, and diagnosis of precursor T cell acute lymphoblastic leukemia/lymphoma&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H814303532\"><span class=\"h1\">EVALUATION</span></p><p class=\"headingAnchor\" id=\"H1463539878\"><span class=\"h2\">Urgency of evaluation</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The urgency of evaluation of lymphocytosis is guided by the patient's clinical condition, the degree and rate of rise of lymphocytosis (if known), and worrisome findings (eg, leukemic blasts) on the blood smear.</p><p>As examples:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Lymphocytosis accompanied by hemodynamic instability, respiratory compromise, or other clinical emergency requires immediate hospitalization and urgent evaluation.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Asymptomatic lymphocytosis without worrisome findings on blood smear or blood chemistries may be evaluated as an outpatient. (See <a href=\"#H4177589950\" class=\"local\">'Peripheral blood smear'</a> below.)</p><p/><p>No specific level of lymphocytosis constitutes a medical emergency. The response to marked lymphocytosis is influenced by whether a diagnosis has previously been established.</p><p>As examples:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>If the cause of lymphocytosis is <strong>not</strong> known, an absolute lymphocyte count (ALC) &gt;50,000 <span class=\"nowrap\">cells/microL</span> may require prompt evaluation and hematology consultation to make an initial assessment about the urgency of further testing. (See <a href=\"topic.htm?path=approach-to-the-patient-with-neutrophilia#H23\" class=\"medical medical_review\">&quot;Approach to the patient with neutrophilia&quot;, section on 'Leukemoid reaction/hyperleukocytosis'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Conversely, an asymptomatic, clinically stable patient with documented chronic lymphocytic leukemia (CLL) does not require urgent hematologic consultation based on elevated ALC alone; a patient with documented CLL may remain asymptomatic and clinically stable irrespective of the degree of lymphocytosis. </p><p/><p class=\"headingAnchor\" id=\"H1561988821\"><span class=\"h2\">Initial evaluation</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Lymphocytosis may be encountered in the course of evaluating other clinical findings or as an incidental abnormality on a complete blood count (CBC) and differential.</p><p>Initial evaluation of lymphocytosis includes CBC, history and physical examination, and review of the blood smear.</p><p>The initial evaluation of lymphocytosis cannot determine clonality or the subtype of lymphocytes (ie, B versus T versus NK cells); such conclusions require flow cytometry or other specialized tests, as described below. (See <a href=\"#H2808185909\" class=\"local\">'Distinguishing clonal versus polyclonal processes'</a> below.)</p><p class=\"headingAnchor\" id=\"H1919057392\"><span class=\"h3\">Complete blood count (CBC)</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The abnormal CBC and differential count should be repeated to exclude laboratory error:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Repeat CBC should be performed immediately if the patient is clinically unstable, worrisome findings are reported (eg, leukemic blasts), or ALC is markedly elevated (eg, &gt;30,000 <span class=\"nowrap\">cells/microL)</span> without a known diagnosis.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The CBC can be repeated with less urgency (eg, within several days) if the patient is clinically stable, the lymphocytosis is modest, and no worrisome findings are reported on blood smear.</p><p/><p>When available, prior CBCs (both normal and abnormal) can provide important information about the duration and trajectory of lymphocytosis.</p><p>ALCs can rise to 20,000 to 30,000 <span class=\"nowrap\">cells/microL</span> in reactive lymphocytoses (eg, infection or inflammation). The higher the ALC is above these values, the lower is the likelihood of a reactive disorder. That is, the likelihood of a malignant disorder increases with ALC <span class=\"nowrap\">&gt;30,000/microL</span> <span class=\"nowrap\">and/or</span> characteristic findings on the blood smear (eg, lymphoblasts, smudge cells). (See <a href=\"#H4177589950\" class=\"local\">'Peripheral blood smear'</a> below.)</p><p>In general, reactive lymphocytosis can be expected to persist while the underlying <span class=\"nowrap\">inflammatory/infectious</span> process is active. Lymphocytosis caused by an acute condition (eg, infection) should resolve within one to two months; a longer duration of lymphocytosis might raise concerns regarding an underlying malignant process.</p><p>Lymphocytosis may be the sole abnormality in the CBC and blood smear, or it may be accompanied by other blood abnormalities, including:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Increased eosinophils or basophils</strong> accompanying lymphocytosis may be due to:</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Allergic conditions or medications (see <a href=\"#H1443801887\" class=\"local\">'Drug hypersensitivity reactions'</a> above)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Infections (see <a href=\"#H1692569306\" class=\"local\">'Infectious causes'</a> above)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Inflammatory conditions (see <a href=\"#H3707269253\" class=\"local\">'Non-infectious causes'</a> above)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Increased neutrophils <span class=\"nowrap\">and/or</span> monocytes </strong>accompanying lymphocytosis may be due to:</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Infections (see <a href=\"#H1692569306\" class=\"local\">'Infectious causes'</a> above)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Inflammatory conditions (see <a href=\"#H3707269253\" class=\"local\">'Non-infectious causes'</a> above)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Medications (see <a href=\"#H1443801887\" class=\"local\">'Drug hypersensitivity reactions'</a> above)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Severe medical stress or other conditions (eg, asplenia) (see <a href=\"#H3707269253\" class=\"local\">'Non-infectious causes'</a> above)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Anemia </strong>&ndash; Anemia associated with lymphocytosis can have varied causes. Examples include:</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Hemolytic anemia or pure red cell aplasia associated with CLL or large granular lymphocyte leukemia (see <a href=\"topic.htm?path=clinical-presentation-pathologic-features-diagnosis-and-differential-diagnosis-of-chronic-lymphocytic-leukemia#H602942893\" class=\"medical medical_review\">&quot;Clinical presentation, pathologic features, diagnosis, and differential diagnosis of chronic lymphocytic leukemia&quot;, section on 'Cytopenias'</a> and <a href=\"topic.htm?path=clinical-manifestations-pathologic-features-and-diagnosis-of-t-cell-large-granular-lymphocyte-leukemia#H458740684\" class=\"medical medical_review\">&quot;Clinical manifestations, pathologic features, and diagnosis of T cell large granular lymphocyte leukemia&quot;, section on 'Clinical features'</a>)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Anemia of chronic disease associated with chronic inflammatory conditions or infections (see <a href=\"topic.htm?path=anemia-of-chronic-disease-inflammation\" class=\"medical medical_review\">&quot;Anemia of chronic disease/inflammation&quot;</a>)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Bone marrow infiltration by various leukemias and infections</p><p/><p class=\"bulletIndent1\">Clinical evaluation of anemia is discussed in greater detail separately (see <a href=\"topic.htm?path=approach-to-the-adult-with-anemia\" class=\"medical medical_review\">&quot;Approach to the adult with anemia&quot;</a>) &#160;</p><p/><p class=\"headingAnchor\" id=\"H1556973766\"><span class=\"h3\">History and physical examination</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The history should seek evidence of disorders that might account for lymphocytosis. (See <a href=\"#H2705667192\" class=\"local\">'Causes of lymphocytosis'</a> above.)</p><p>Important aspects of the history include evidence of:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Active or prior infection or inflammatory processes (eg, trauma, seizure, arthritis, rash). (See <a href=\"#H2705667192\" class=\"local\">'Causes of lymphocytosis'</a> above.) </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Previously diagnosed hematologic malignancy (eg, lymphoma, leukemia) or related symptoms <span class=\"nowrap\">and/or</span> signs (eg, unexplained lymphadenopathy, fevers, sweats, weight loss). (See <a href=\"#H1516036561\" class=\"local\">'Clonal processes'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Surgical or functional asplenia. (See <a href=\"#H992688327\" class=\"local\">'Asplenia'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Medications, including the association between the onset of lymphocytosis (if known) and onset of drugs associated with drug reaction with eosinophilia and systemic symptoms (DRESS) (<a href=\"image.htm?imageKey=DERM%2F86760\" class=\"graphic graphic_table graphicRef86760 \">table 1</a>). (See <a href=\"topic.htm?path=drug-reaction-with-eosinophilia-and-systemic-symptoms-dress\" class=\"medical medical_review\">&quot;Drug reaction with eosinophilia and systemic symptoms (DRESS)&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Cigarette smoking. (See <a href=\"#H3698562569\" class=\"local\">'Persistent polyclonal B cell lymphocytosis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Family history of lymphoid neoplasms or lymphocytosis. (See <a href=\"#H1359939611\" class=\"local\">'Monoclonal B lymphocytosis'</a> above.)</p><p/><p>Physical examination should seek evidence of infection, inflammation, or malignancy, such as fever, lymphadenopathy, hepatosplenomegaly, joint redness, abdominal pain, and lung findings.</p><p>The presence of lymphadenopathy <span class=\"nowrap\">and/or</span> splenomegaly does not indicate whether the lymphocytosis is malignant versus reactive (ie, infectious or non-infectious) because those clinical findings can be associated with either category of disease.</p><p class=\"headingAnchor\" id=\"H4177589950\"><span class=\"h3\">Peripheral blood smear</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The peripheral blood smear should be reviewed to assess lymphocyte morphology and detect other hematologic findings.</p><p>Examples of lymphocyte findings on the blood smear include:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Normal-appearing small lymphocytes may be seen with certain infections (eg, pertussis), CLL, monoclonal B cell lymphocytosis, and other disorders.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Atypical lymphocytes (ie, large lymphocytes with abundant basophilic cytoplasm and a large, irregularly shaped nucleus that may exhibit nucleoli) (<a href=\"image.htm?imageKey=HEME%2F55986\" class=\"graphic graphic_picture graphicRef55986 \">picture 1</a>) are often seen in infectious mononucleosis and other viral illnesses (<a href=\"image.htm?imageKey=HEME%2F58246\" class=\"graphic graphic_table graphicRef58246 \">table 3</a>).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Binucleate lymphocytes are characteristic of persistent polyclonal B cell lymphocytosis (PPBL). (See <a href=\"#H3698562569\" class=\"local\">'Persistent polyclonal B cell lymphocytosis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Normal maturing B lymphocyte precursors (so-called &quot;hematogones&quot;) can be mistaken for lymphoblasts and represent 0.01 to 1.3 percent of leukocytes in adults, as detected by sensitive flow cytometry methods [<a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/43-45\" class=\"abstract_t\">43-45</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Distinctive lymphoid forms may be seen in certain malignant disorders, including:</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>&quot;Smudge&quot; lymphocytes (<a href=\"image.htm?imageKey=HEME%2F54469\" class=\"graphic graphic_picture graphicRef54469 \">picture 7</a>) are characteristic (but not diagnostic) of CLL. (See <a href=\"topic.htm?path=clinical-presentation-pathologic-features-diagnosis-and-differential-diagnosis-of-chronic-lymphocytic-leukemia#H3\" class=\"medical medical_review\">&quot;Clinical presentation, pathologic features, diagnosis, and differential diagnosis of chronic lymphocytic leukemia&quot;, section on 'Morphology'</a>.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Villous projections (<a href=\"image.htm?imageKey=HEME%2F59065\" class=\"graphic graphic_picture graphicRef59065 \">picture 8</a>) may be seen with splenic marginal zone lymphoma. (See <a href=\"topic.htm?path=splenic-marginal-zone-lymphoma#H6\" class=\"medical medical_review\">&quot;Splenic marginal zone lymphoma&quot;, section on 'Morphology'</a>.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>&quot;Hair-like&quot; projections (<a href=\"image.htm?imageKey=HEME%2F102936\" class=\"graphic graphic_picture graphicRef102936 \">picture 9</a>) are seen in hairy cell leukemia. (See <a href=\"topic.htm?path=clinical-features-and-diagnosis-of-hairy-cell-leukemia#H8\" class=\"medical medical_review\">&quot;Clinical features and diagnosis of hairy cell leukemia&quot;, section on 'Morphology'</a>.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Small lymphocytes with cleaved nuclei (<a href=\"image.htm?imageKey=HEME%2F65023\" class=\"graphic graphic_picture graphicRef65023 \">picture 10</a>) may be seen with follicular lymphoma and mantle cell lymphoma. (See <a href=\"topic.htm?path=clinical-manifestations-pathologic-features-diagnosis-and-prognosis-of-follicular-lymphoma#H12\" class=\"medical medical_review\">&quot;Clinical manifestations, pathologic features, diagnosis, and prognosis of follicular lymphoma&quot;, section on 'Blood and bone marrow'</a>.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Lymphocytes with &quot;cerebriform&quot; nuclei (ie, S&eacute;zary cells) (<a href=\"image.htm?imageKey=HEME%2F70592\" class=\"graphic graphic_picture graphicRef70592 \">picture 11</a>) are seen in S&eacute;zary <span class=\"nowrap\">syndrome/mycosis</span> fungoides. (See <a href=\"topic.htm?path=clinical-manifestations-pathologic-features-and-diagnosis-of-mycosis-fungoides#H13602155\" class=\"medical medical_review\">&quot;Clinical manifestations, pathologic features, and diagnosis of mycosis fungoides&quot;, section on 'Circulating S&eacute;zary cells'</a>.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Lymphocytes with azurophilic granules (<a href=\"image.htm?imageKey=HEME%2F69027\" class=\"graphic graphic_picture graphicRef69027 \">picture 4</a>) may be seen in large granular lymphocyte leukemia. (See <a href=\"topic.htm?path=clinical-manifestations-pathologic-features-and-diagnosis-of-t-cell-large-granular-lymphocyte-leukemia#H113798345\" class=\"medical medical_review\">&quot;Clinical manifestations, pathologic features, and diagnosis of T cell large granular lymphocyte leukemia&quot;, section on 'Peripheral blood'</a>.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Lymphoblasts can vary from cells with little cytoplasm (<a href=\"image.htm?imageKey=HEME%2F57831\" class=\"graphic graphic_picture graphicRef57831 \">picture 12</a>) to abundant bluish cytoplasm (<a href=\"image.htm?imageKey=HEME%2F65474\" class=\"graphic graphic_picture graphicRef65474 \">picture 6</a>) or deep blue cytoplasm (<a href=\"image.htm?imageKey=HEME%2F57366\" class=\"graphic graphic_picture graphicRef57366 \">picture 13</a>) in acute lymphoblastic leukemia (ALL). (See <a href=\"topic.htm?path=clinical-manifestations-pathologic-features-and-diagnosis-of-precursor-b-cell-acute-lymphoblastic-leukemia-lymphoma\" class=\"medical medical_review\">&quot;Clinical manifestations, pathologic features, and diagnosis of precursor B cell acute lymphoblastic leukemia/lymphoma&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H1108550043\"><span class=\"h3\">Other laboratory tests</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Other laboratory tests may be included in the initial evaluation to help distinguish malignant disorders from reactive causes of lymphocytosis <span class=\"nowrap\">and/or</span> identify associated clinical findings or complications include:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Kidney and liver function tests</strong> may identify associated medical conditions or complications (eg, acute kidney injury due to tumor lysis syndrome associated with ALL).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP)</strong> are elevated in inflammation and infection, and may be helpful in evaluating the cause of lymphocytosis; as an example, elevated ESR <span class=\"nowrap\">and/or</span> CRP in an asymptomatic patient may suggest an underlying inflammatory condition.</p><p/><p class=\"headingAnchor\" id=\"H2239204061\"><span class=\"h1\">ASSESSMENT OF CLONALITY</span></p><p class=\"headingAnchor\" id=\"H2808185909\"><span class=\"h2\">Distinguishing clonal versus polyclonal processes</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Distinguishing clonal from polyclonal processes is often an important step in determining the cause of lymphocytosis. Clonality cannot be determined by the initial evaluation (ie, history, physical examination, complete blood count [CBC], and blood smear).</p><p>For most patients, flow cytometry is the preferred initial technique to define clonality, as described below. (See <a href=\"#H2916269538\" class=\"local\">'Selection of specialized tests'</a> below.)</p><p>While all malignant lymphocytosis is clonal, not all clonal expansions are malignant; some infectious or inflammatory causes of lymphocytosis may be associated with oligoclonal expansion of lymphocytes (eg, two to five distinct low-abundance clones).</p><p>Conversely, premalignant disorders (eg, monoclonal B lymphocytosis) or early stages of some leukemias may exhibit only low levels of clonal lymphocytes among a larger population of normal polyclonal lymphocytes; in such cases, the diagnosis may only be revealed with follow up (eg, clinical observation, serial CBCs, <span class=\"nowrap\">and/or</span> repeat flow cytometry or molecular testing).</p><p class=\"headingAnchor\" id=\"H2102219497\"><span class=\"h2\">Which patients require flow cytometry?</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Flow cytometry should <strong>not</strong> be performed in all patients with lymphocytosis.</p><p>A decision to perform flow cytometry and the urgency of testing are informed by the patient's clinical status, the level of lymphocytosis and its trajectory (if known), worrisome findings on blood smear, and clinician <span class=\"nowrap\">and/or</span> patient concern.</p><p>Flow cytometry should be performed promptly when there is:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Suspicion for acute leukemia (eg, lymphoblasts on blood smear) (see <a href=\"#H4177589950\" class=\"local\">'Peripheral blood smear'</a> above)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Absolute lymphocyte count (ALC) &gt;30,000 <span class=\"nowrap\">cells/microL</span> without a known diagnosis</p><p/><p>In less urgent settings, our approach is to repeat the CBC and differential in one to two weeks. We perform flow cytometry of peripheral blood to assess clonality and immunophenotype for the following findings:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>ALC &gt;5000 <span class=\"nowrap\">cells/microL,</span> unless lymphocytosis can be accounted for by evidence of a recent viral infection, offending drug, or asplenia</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Unexplained ALC &gt;4000 <span class=\"nowrap\">cells/microL</span> for &gt;1 month</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Rising ALC</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Lymphocyte morphology suggestive of malignancy (eg, lymphoblasts, smudge cells, hairy cells) (see <a href=\"#H4177589950\" class=\"local\">'Peripheral blood smear'</a> above)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Cytopenias</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hepatosplenomegaly</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Lymphadenopathy</p><p/><p class=\"headingAnchor\" id=\"H2916269538\"><span class=\"h2\">Selection of specialized tests</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Selection of specialized tests is informed by the nature of the clinical questions, the urgency of testing, and the specimens that are available.</p><p>In general, flow cytometry of peripheral blood is the preferred initial test for determining clonality in the patient with lymphocytosis. Compared with other specialized techniques (eg, chromosome analysis, <span class=\"nowrap\">molecular/genetic</span> testing), flow cytometry provides more rapid and cost-effective results, and it can also define lymphocyte lineage. (See <a href=\"#H1891381287\" class=\"local\">'Definitions and normal values'</a> above.)</p><p>In some cases, flow cytometry of peripheral blood may not be necessary in a patient with lymphocytosis. If clonality was already defined by other techniques (eg, immunohistochemistry of a lymph node, molecular testing of a bone marrow specimen), flow cytometry of peripheral blood generally does not need to be performed. </p><p class=\"headingAnchor\" id=\"H78181183\"><span class=\"h2\">Specialized tests for clonality</span></p><p class=\"headingAnchor\" id=\"H2850349690\"><span class=\"h3\">Flow cytometry</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Flow cytometry can define clonality and determine the lineage and immunophenotype of lymphocytes.</p><p>Our approach to deciding when and for whom to perform flow cytometry for evaluation of lymphocytosis is described above. (See <a href=\"#H2102219497\" class=\"local\">'Which patients require flow cytometry?'</a> above.)</p><p>Use of flow cytometry for characterizing lymphocytes is described separately. (See <a href=\"topic.htm?path=flow-cytometry-for-the-diagnosis-of-primary-immunodeficiencies#H2\" class=\"medical medical_review\">&quot;Flow cytometry for the diagnosis of primary immunodeficiencies&quot;, section on 'Technical aspects'</a> and <a href=\"topic.htm?path=detection-of-minimal-residual-disease-in-acute-lymphoblastic-leukemia#H14\" class=\"medical medical_review\">&quot;Detection of minimal residual disease in acute lymphoblastic leukemia&quot;, section on 'Multicolor flow cytometry'</a>.)</p><p class=\"headingAnchor\" id=\"H1839956429\"><span class=\"h3\">Molecular/Genetic testing</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Molecular techniques that can detect clonal populations of lymphocytes include polymerase chain reaction (PCR) and DNA sequencing. </p><p>These techniques can demonstrate the presence of a dominant clone of cells based on rearrangements of either immunoglobulin genes (in B lymphocyte) or T cell receptor genes (in T cells). NK cells are not amenable to such testing, but clonal integration of Epstein-Barr virus (EBV) may be detected in some cases [<a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/46\" class=\"abstract_t\">46</a>]. (See <a href=\"topic.htm?path=natural-killer-nk-cell-large-granular-lymphocyte-leukemia#H14\" class=\"medical medical_review\">&quot;Natural killer (NK) cell large granular lymphocyte leukemia&quot;, section on 'Laboratory findings'</a>.)</p><p>Additional aspects of PCR and DNA sequencing are provided separately. (See <a href=\"topic.htm?path=genetic-testing#H18\" class=\"medical medical_review\">&quot;Genetic testing&quot;, section on 'Principles of genetic testing'</a>.)</p><p class=\"headingAnchor\" id=\"H2981944586\"><span class=\"h3\">Chromosome analysis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Chromosome analysis by conventional karyotype or fluorescence in situ hybridization can identify acquired and inherited causes of lymphocytosis, especially in certain lymphoid leukemias and lymphomas.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>FISH</strong> &ndash; Fluorescence in situ hybridization (FISH) on peripheral blood, bone marrow, or lymph nodes can help to define the category of malignant lymphocytosis.</p><p/><p class=\"bulletIndent1\">FISH is particularly important in diagnosing clonal disorders that are not definitively identified based on morphology and immunophenotype. One important example is the t(11;14) probe for <em><span class=\"nowrap\">CCND1/IgH</em>,</span> which is positive in mantle cell lymphoma (MCL) and negative in other lymphoid malignancies. (See <a href=\"topic.htm?path=tools-for-genetics-and-genomics-cytogenetics-and-molecular-genetics#H15538631\" class=\"medical medical_review\">&quot;Tools for genetics and genomics: Cytogenetics and molecular genetics&quot;, section on 'Fluorescence in situ hybridization'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Karyotype</strong> &ndash; An abnormal karyotype is seen in some cases of adult ALL, CLL, MCL, and other hematologic malignancies. Additional description is provided separately. (See <a href=\"topic.htm?path=cytogenetics-and-molecular-genetics-in-acute-lymphoblastic-leukemia\" class=\"medical medical_review\">&quot;Cytogenetics and molecular genetics in acute lymphoblastic leukemia&quot;</a> and <a href=\"topic.htm?path=general-aspects-of-cytogenetic-analysis-in-hematologic-malignancies\" class=\"medical medical_review\">&quot;General aspects of cytogenetic analysis in hematologic malignancies&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H330925166\"><span class=\"h1\">LYMPHOCYTOPENIA</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Lymphocytopenia refers to an absolute lymphocyte count (ALC) below a lower threshold, which differs by age. (See <a href=\"#H1891381287\" class=\"local\">'Definitions and normal values'</a> above.)</p><p class=\"headingAnchor\" id=\"H330925184\"><span class=\"h2\">Causes and evaluation</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The causes of lymphocytopenia (<a href=\"image.htm?imageKey=HEME%2F58469\" class=\"graphic graphic_table graphicRef58469 \">table 4</a>) include infections such as human immunodeficiency virus (HIV); protein-energy undernutrition; systemic disease; congenital immunodeficiency disorders, such as common variable immunodeficiency; and chemotherapy or immunosuppressive therapy, including glucocorticoids.</p><p>The patient evaluation is guided by the history and physical examination. When the underlying diagnosis is not obvious from the initial evaluation and review of the medication list for possible medication triggers, we assess HIV status and measure lymphocyte subpopulations and immunoglobulin levels. Additional testing for suspected primary immunodeficiency is described separately. (See <a href=\"topic.htm?path=laboratory-evaluation-of-the-immune-system\" class=\"medical medical_review\">&quot;Laboratory evaluation of the immune system&quot;</a>.)</p><p>Examples of common findings and typical presentations are illustrated by the following:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In a study of 1042 hospitalized adults with an ALC <span class=\"nowrap\">&lt;600/microL</span> in a teaching hospital, the most common causes for lymphocytopenia were as follows [<a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/47\" class=\"abstract_t\">47</a>]:</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Bacterial or fungal sepsis &ndash; 24 percent</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Postoperative state &ndash; 22 percent</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Malignancy &ndash; 17 percent</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Use of glucocorticoids &ndash; 15 percent</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Cytotoxic chemotherapy <span class=\"nowrap\">and/or</span> radiation therapy &ndash; 9 percent</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Trauma or hemorrhage &ndash; 8 percent</p><p/><p class=\"bulletIndent1\">For the 698 patients in this study who had previous and subsequent blood counts, lymphocytopenia was persistently present in only 6 percent.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Patients with immunodeficiency due to primary or secondary immunodeficiency syndromes may present with a range of disorders, such as:</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Recurrent infections</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Autoimmune disorders</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Inflammatory disorders (eg, inflammatory bowel disease, inflammatory arthritis)</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Malignancies (eg, lymphoma)</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Allergic disease (eg, atopic dermatitis, food allergy, allergic rhinosinusitis, asthma)</p><p/><p class=\"bulletIndent1\">In addition to a reduction in the total number of circulating lymphocytes, a deficiency of one or more lymphocyte subsets may occur (eg, B cells, T cells, NK cells) and can be characteristic of a number of specific disorders. (See <a href=\"topic.htm?path=primary-humoral-immunodeficiencies-an-overview\" class=\"medical medical_review\">&quot;Primary humoral immunodeficiencies: An overview&quot;</a> and <a href=\"topic.htm?path=combined-immunodeficiencies\" class=\"medical medical_review\">&quot;Combined immunodeficiencies&quot;</a> and <a href=\"topic.htm?path=severe-combined-immunodeficiency-scid-an-overview\" class=\"medical medical_review\">&quot;Severe combined immunodeficiency (SCID): An overview&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H330925285\"><span class=\"h2\">Management (lymphocytopenia)</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Management of lymphocytopenia depends on the underlying condition responsible and may include therapy related to associated cytopenias <span class=\"nowrap\">and/or</span> other immune defects.</p><p>If the patient has an immunodeficiency syndrome associated with hypogammaglobulinemia, immunoglobulin replacement therapy may be administered. (See <a href=\"topic.htm?path=immune-globulin-therapy-in-primary-immunodeficiency\" class=\"medical medical_review\">&quot;Immune globulin therapy in primary immunodeficiency&quot;</a>.)</p><p>Hematopoietic cell transplantation (HCT) can be considered for patients with congenital immunodeficiencies and has curative potential in these patients. (See <a href=\"topic.htm?path=hematopoietic-cell-transplantation-for-primary-immunodeficiency\" class=\"medical medical_review\">&quot;Hematopoietic cell transplantation for primary immunodeficiency&quot;</a>.)</p><p>In contrast, we generally do not intervene for patients with asymptomatic lymphocytopenia without an associated illness.</p><p class=\"headingAnchor\" id=\"H330925315\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Lymphocytosis typically refers to &gt;4000 <span class=\"nowrap\">lymphocytes/microL</span> in adults. (See <a href=\"#H1891381287\" class=\"local\">'Definitions and normal values'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Lymphocytosis may be polyclonal (reactive) or clonal (malignant). Reactive lymphocytosis can be due to infectious or non-infectious causes (<a href=\"image.htm?imageKey=HEME%2F58246\" class=\"graphic graphic_table graphicRef58246 \">table 3</a>). Clonal causes of lymphocytosis include premalignant causes (eg, monoclonal B lymphocytosis) and various lymphoid malignancies. (See <a href=\"#H2705667192\" class=\"local\">'Causes of lymphocytosis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The urgency of evaluation of lymphocytosis is guided by the patient's clinical condition, the degree and rate of rise of lymphocytosis (if known), and worrisome findings (eg, leukemic blasts) on the blood smear. (See <a href=\"#H1463539878\" class=\"local\">'Urgency of evaluation'</a> above.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Lymphocytosis accompanied by clinical instability usually requires immediate hospitalization and urgent evaluation.</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Asymptomatic, modest lymphocytosis without worrisome findings may be monitored and evaluated as an outpatient. </p><p/><p class=\"bulletIndent1\">The urgency of evaluation is also influenced by the level of lymphocyte count, but there is no threshold value that constitutes a medical emergency. Unknown causes for absolute lymphocyte count (ALC) &gt;50,000 <span class=\"nowrap\">cells/microL</span> may require prompt evaluation and hematology consultation.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In the initial evaluation, the abnormal complete blood count (CBC) and differential count should be repeated to exclude laboratory error, with the urgency of retesting informed by clinical status, worrisome findings (eg, leukemic blasts), or markedly elevated ALC (eg, &gt;30,000 <span class=\"nowrap\">cells/microL)</span> without a known diagnosis. (See <a href=\"#H1919057392\" class=\"local\">'Complete blood count (CBC)'</a> above.)</p><p/><p class=\"bulletIndent1\">Review of the blood smear may reveal findings suggestive of certain infectious or malignant disorders. (See <a href=\"#H4177589950\" class=\"local\">'Peripheral blood smear'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Follow-up evaluation to distinguish clonal versus polyclonal processes is required in only a subset of patients. In general, flow cytometry of peripheral blood is the preferred initial test for determining clonality in the patient with lymphocytosis. (See <a href=\"#H2808185909\" class=\"local\">'Distinguishing clonal versus polyclonal processes'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Urgent flow cytometry should be performed for suspicion of acute leukemia (eg, lymphoblasts on blood smear) or lymphocytosis &gt;30,000 <span class=\"nowrap\">cells/microL</span> without a known diagnosis. (See <a href=\"#H2102219497\" class=\"local\">'Which patients require flow cytometry?'</a> above.)</p><p/><p class=\"bulletIndent1\">In less urgent settings, our approach is to repeat the CBC and differential in one to two weeks and perform flow cytometry of peripheral blood to assess clonality and immunophenotype for the following findings (see <a href=\"#H2102219497\" class=\"local\">'Which patients require flow cytometry?'</a> above):</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>ALC &gt;5000 <span class=\"nowrap\">cells/microL,</span> unless lymphocytosis can be accounted for by another cause</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Unexplained ALC &gt;4000 <span class=\"nowrap\">cells/microL</span> for &gt;1 month</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Rising ALC</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Lymphocyte morphology suggestive of malignancy (eg, lymphoblasts, smudge cells, hairy cells)</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Cytopenias</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Hepatosplenomegaly</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Lymphadenopathy</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The causes of lymphocytopenia include infections such as human immunodeficiency virus (HIV), protein-energy undernutrition, systemic disease, congenital immunodeficiency disorders such as Wiskott-Aldrich syndrome or severe-combined immunodeficiency disorder, and chemotherapy or immunosuppressive therapy (<a href=\"image.htm?imageKey=HEME%2F58469\" class=\"graphic graphic_table graphicRef58469 \">table 4</a>). The evaluation is guided by the history and physical examination. When the underlying diagnosis is not obvious from the initial evaluation, we assess HIV status, lymphocyte subpopulations, and immunoglobulin levels. (See <a href=\"#H330925166\" class=\"local\">'Lymphocytopenia'</a> above.)</p><p/><p class=\"headingAnchor\" id=\"H4032127999\"><span class=\"h1\">ACKNOWLEDGMENT</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>UpToDate would like to acknowledge Nancy Berliner, MD, who contributed to earlier versions of this topic review.</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/1\" class=\"nounderline abstract_t\">Vetsika EK, Callan M. Infectious mononucleosis and Epstein-Barr virus. Expert Rev Mol Med 2004; 6:1.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/2\" class=\"nounderline abstract_t\">Heininger U, Stehr K, Schmitt-Groh&eacute; S, et al. Clinical characteristics of illness caused by Bordetella parapertussis compared with illness caused by Bordetella pertussis. Pediatr Infect Dis J 1994; 13:306.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/3\" class=\"nounderline abstract_t\">Kubic VL, Kubic PT, Brunning RD. The morphologic and immunophenotypic assessment of the lymphocytosis accompanying Bordetella pertussis infection. Am J Clin Pathol 1991; 95:809.</a></li><li class=\"breakAll\">Margileth AM. Cat scratch disease. In: Nelson Textbook of Pediatrics, 15th ed, Behrman RE, Kliegman RM, Arvin AM (Eds), WB Saunders, Philadelphia 1996.</li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/5\" class=\"nounderline abstract_t\">Teggatz JR, Parkin J, Peterson L. Transient atypical lymphocytosis in patients with emergency medical conditions. Arch Pathol Lab Med 1987; 111:712.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/6\" class=\"nounderline abstract_t\">Kho AN, Hui S, Kesterson JG, McDonald CJ. Which observations from the complete blood cell count predict mortality for hospitalized patients? J Hosp Med 2007; 2:5.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/7\" class=\"nounderline abstract_t\">Casassus P, Lortholary P, Komarover H, et al. Cigarette smoking-related persistent polyclonal B lymphocytosis. A premalignant state. Arch Pathol Lab Med 1987; 111:1081.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/8\" class=\"nounderline abstract_t\">Delannoy A, Djian D, Wallef G, et al. Cigarette smoking and chronic polyclonal B-cell lymphocytosis. Nouv Rev Fr Hematol 1993; 35:141.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/9\" class=\"nounderline abstract_t\">Troussard X, Mossafa H, Valensi F, et al. [Polyclonal lymphocytosis with binucleated lymphocytes. Morphological, immunological, cytogenetic and molecular analysis in 15 cases]. Presse Med 1997; 26:895.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/10\" class=\"nounderline abstract_t\">Lesesve JF, Troussard X. Persistent polyclonal B-cell lymphocytosis. Blood 2011; 118:6485.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/11\" class=\"nounderline abstract_t\">Troussard X, Cornet E, Lesesve JF, et al. Polyclonal B-cell lymphocytosis with binucleated lymphocytes (PPBL). Onco Targets Ther 2008; 1:59.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/12\" class=\"nounderline abstract_t\">Cornet E, Lesesve JF, Mossafa H, et al. Long-term follow-up of 111 patients with persistent polyclonal B-cell lymphocytosis with binucleated lymphocytes. Leukemia 2009; 23:419.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/13\" class=\"nounderline abstract_t\">Delage R, Roy J, Jacques L, Darveau A. All patients with persistent polyclonal B cell lymphocytosis present Bcl-2/Ig gene rearrangements. Leuk Lymphoma 1998; 31:567.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/14\" class=\"nounderline abstract_t\">Dasanu CA, Codreanu I. Persistent polyclonal B-cell lymphocytosis in chronic smokers: more than meets the eye. Conn Med 2012; 76:69.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/15\" class=\"nounderline abstract_t\">Loemb&eacute; MM, Lamoureux J, Deslauriers N, et al. Lack of CD40-dependent B-cell proliferation in B lymphocytes isolated from patients with persistent polyclonal B-cell lymphocytosis. Br J Haematol 2001; 113:699.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/16\" class=\"nounderline abstract_t\">Himmelmann A, Gautschi O, Nawrath M, et al. Persistent polyclonal B-cell lymphocytosis is an expansion of functional IgD(+)CD27(+) memory B cells. Br J Haematol 2001; 114:400.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/17\" class=\"nounderline abstract_t\">Salcedo I, Campos-Caro A, Sampalo A, et al. Persistent polyclonal B lymphocytosis: an expansion of cells showing IgVH gene mutations and phenotypic features of normal lymphocytes from the CD27+ marginal zone B-cell compartment. Br J Haematol 2002; 116:662.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/18\" class=\"nounderline abstract_t\">Delage R, Jacques L, Massinga-Loembe M, et al. Persistent polyclonal B-cell lymphocytosis: further evidence for a genetic disorder associated with B-cell abnormalities. Br J Haematol 2001; 114:666.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/19\" class=\"nounderline abstract_t\">Juneja S, Januszewicz E, Wolf M, Cooper I. Post-splenectomy lymphocytosis. Clin Lab Haematol 1995; 17:335.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/20\" class=\"nounderline abstract_t\">Garcia-Suarez J, Prieto A, Reyes E, et al. Persistent lymphocytosis of natural killer cells in autoimmune thrombocytopenic purpura (ATP) patients after splenectomy. Br J Haematol 1995; 89:653.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/21\" class=\"nounderline abstract_t\">Doll DC, Landreneau RJ, List AF. Malignant thymoma associated with peripheral T-cell lymphocytosis. Med Pediatr Oncol 1991; 19:496.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/22\" class=\"nounderline abstract_t\">Barton AD. T-cell lymphocytosis associated with lymphocyte-rich thymoma. Cancer 1997; 80:1409.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/23\" class=\"nounderline abstract_t\">Cranney A, Markman S, Lach B, Karsh J. Polymyositis in a patient with thymoma and T cell lymphocytosis. J Rheumatol 1997; 24:1413.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/24\" class=\"nounderline abstract_t\">Otton SH, Standen GR, Ormerod IE. T cell lymphocytosis associated with polymyositis, myasthenia gravis and thymoma. Clin Lab Haematol 2000; 22:307.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/25\" class=\"nounderline abstract_t\">Matos DM, Falc&atilde;o RP. Monoclonal B-cell lymphocytosis: a brief review for general clinicians. Sao Paulo Med J 2011; 129:171.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/26\" class=\"nounderline abstract_t\">Dighiero G. Monoclonal B-cell lymphocytosis--a frequent premalignant condition. N Engl J Med 2008; 359:638.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/27\" class=\"nounderline abstract_t\">Shanafelt TD, Ghia P, Lanasa MC, et al. Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management. Leukemia 2010; 24:512.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/28\" class=\"nounderline abstract_t\">Kalpadakis C, Pangalis GA, Sachanas S, et al. New insights into monoclonal B-cell lymphocytosis. Biomed Res Int 2014; 2014:258917.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/29\" class=\"nounderline abstract_t\">Rawstron AC, Bennett FL, O'Connor SJ, et al. Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia. N Engl J Med 2008; 359:575.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/30\" class=\"nounderline abstract_t\">Strati P, Shanafelt TD. Monoclonal B-cell lymphocytosis and early-stage chronic lymphocytic leukemia: diagnosis, natural history, and risk stratification. Blood 2015; 126:454.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/31\" class=\"nounderline abstract_t\">Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 2016; 127:2375.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/32\" class=\"nounderline abstract_t\">Marti GE, Rawstron AC, Ghia P, et al. Diagnostic criteria for monoclonal B-cell lymphocytosis. Br J Haematol 2005; 130:325.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/33\" class=\"nounderline abstract_t\">Rawstron AC, Ssemaganda A, de Tute R, et al. Monoclonal B-cell lymphocytosis in a hospital-based UK population and a rural Ugandan population: a cross-sectional study. Lancet Haematol 2017; 4:e334.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/34\" class=\"nounderline abstract_t\">Shim YK, Rachel JM, Ghia P, et al. Monoclonal B-cell lymphocytosis in healthy blood donors: an unexpectedly common finding. Blood 2014; 123:1319.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/35\" class=\"nounderline abstract_t\">Mowery YM, Lanasa MC. Clinical aspects of monoclonal B-cell lymphocytosis. Cancer Control 2012; 19:8.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/36\" class=\"nounderline abstract_t\">Perz JB, Ritgen M, Moos M, et al. Occurrence of donor-derived CLL 8 years after sibling donor SCT for CML. Bone Marrow Transplant 2008; 42:687.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/37\" class=\"nounderline abstract_t\">Hardy NM, Grady C, Pentz R, et al. Bioethical considerations of monoclonal B-cell lymphocytosis: donor transfer after haematopoietic stem cell transplantation. Br J Haematol 2007; 139:824.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/38\" class=\"nounderline abstract_t\">Ferrand C, Garnache-Ottou F, Collonge-Rame MA, et al. Systematic donor blood qualification by flow cytometry would have been able to avoid CLL-type MBL transmission after unrelated hematopoietic stem cell transplantation. Eur J Haematol 2012; 88:269.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/39\" class=\"nounderline abstract_t\">Snow AL, Xiao W, Stinson JR, et al. Congenital B cell lymphocytosis explained by novel germline CARD11 mutations. J Exp Med 2012; 209:2247.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/40\" class=\"nounderline abstract_t\">Bockorny B, Dasanu CA. Autoimmune manifestations in large granular lymphocyte leukemia. Clin Lymphoma Myeloma Leuk 2012; 12:400.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/41\" class=\"nounderline abstract_t\">Pontikoglou C, Kalpadakis C, Papadaki HA. Pathophysiologic mechanisms and management of neutropenia associated with large granular lymphocytic leukemia. Expert Rev Hematol 2011; 4:317.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/42\" class=\"nounderline abstract_t\">Liu X, Loughran TP Jr. The spectrum of large granular lymphocyte leukemia and Felty's syndrome. Curr Opin Hematol 2011; 18:254.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/43\" class=\"nounderline abstract_t\">Brady KA, Atwater SK, Lowell CA. Flow cytometric detection of CD10 (cALLA) on peripheral blood B lymphocytes of neonates. Br J Haematol 1999; 107:712.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/44\" class=\"nounderline abstract_t\">Chantepie SP, Sala&uuml;n V, Parienti JJ, et al. Hematogones: a new prognostic factor for acute myeloblastic leukemia. Blood 2011; 117:1315.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/45\" class=\"nounderline abstract_t\">Sevilla DW, Colovai AI, Emmons FN, et al. Hematogones: a review and update. Leuk Lymphoma 2010; 51:10.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/46\" class=\"nounderline abstract_t\">Kanegane H, Yachie A, Miyawaki T, Tosato G. EBV-NK cells interactions and lymphoproliferative disorders. Leuk Lymphoma 1998; 29:491.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-adult-with-lymphocytosis-or-lymphocytopenia/abstract/47\" class=\"nounderline abstract_t\">Castelino DJ, McNair P, Kay TW. Lymphocytopenia in a hospital population--what does it signify? Aust N Z J Med 1997; 27:170.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 104124 Version 11.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H330925315\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H330922311\" id=\"outline-link-H330922311\">INTRODUCTION</a></li><li><a href=\"#H1891381287\" id=\"outline-link-H1891381287\">DEFINITIONS AND NORMAL VALUES</a></li><li><a href=\"#H1031225720\" id=\"outline-link-H1031225720\">MECHANISMS</a></li><li><a href=\"#H2705667192\" id=\"outline-link-H2705667192\">CAUSES OF LYMPHOCYTOSIS</a><ul><li><a href=\"#H1692569306\" id=\"outline-link-H1692569306\">Infectious causes</a></li><li><a href=\"#H3707269253\" id=\"outline-link-H3707269253\">Non-infectious causes</a><ul><li><a href=\"#H1443801887\" id=\"outline-link-H1443801887\">- Drug hypersensitivity reactions</a></li><li><a href=\"#H1909659640\" id=\"outline-link-H1909659640\">- Stress</a></li><li><a href=\"#H3698562569\" id=\"outline-link-H3698562569\">- Persistent polyclonal B cell lymphocytosis</a></li><li><a href=\"#H992688327\" id=\"outline-link-H992688327\">- Asplenia</a></li><li><a href=\"#H219026063\" id=\"outline-link-H219026063\">- Thymoma</a></li></ul></li><li><a href=\"#H1516036561\" id=\"outline-link-H1516036561\">Clonal processes</a><ul><li><a href=\"#H1359939611\" id=\"outline-link-H1359939611\">- Monoclonal B lymphocytosis</a></li><li><a href=\"#H1951432233\" id=\"outline-link-H1951432233\">- Congenital B cell lymphocytosis</a></li><li><a href=\"#H2679685677\" id=\"outline-link-H2679685677\">- Large granular lymphocyte leukemia</a></li><li><a href=\"#H1616252797\" id=\"outline-link-H1616252797\">- Chronic lymphocytic leukemia</a></li><li><a href=\"#H3993973188\" id=\"outline-link-H3993973188\">- Non-Hodgkin lymphoma</a></li><li><a href=\"#H2376257218\" id=\"outline-link-H2376257218\">- Acute lymphoblastic leukemia</a></li></ul></li></ul></li><li><a href=\"#H814303532\" id=\"outline-link-H814303532\">EVALUATION</a><ul><li><a href=\"#H1463539878\" id=\"outline-link-H1463539878\">Urgency of evaluation</a></li><li><a href=\"#H1561988821\" id=\"outline-link-H1561988821\">Initial evaluation</a><ul><li><a href=\"#H1919057392\" id=\"outline-link-H1919057392\">- Complete blood count (CBC)</a></li><li><a href=\"#H1556973766\" id=\"outline-link-H1556973766\">- History and physical examination</a></li><li><a href=\"#H4177589950\" id=\"outline-link-H4177589950\">- Peripheral blood smear</a></li><li><a href=\"#H1108550043\" id=\"outline-link-H1108550043\">- Other laboratory tests</a></li></ul></li></ul></li><li><a href=\"#H2239204061\" id=\"outline-link-H2239204061\">ASSESSMENT OF CLONALITY</a><ul><li><a href=\"#H2808185909\" id=\"outline-link-H2808185909\">Distinguishing clonal versus polyclonal processes</a></li><li><a href=\"#H2102219497\" id=\"outline-link-H2102219497\">Which patients require flow cytometry?</a></li><li><a href=\"#H2916269538\" id=\"outline-link-H2916269538\">Selection of specialized tests</a></li><li><a href=\"#H78181183\" id=\"outline-link-H78181183\">Specialized tests for clonality</a><ul><li><a href=\"#H2850349690\" id=\"outline-link-H2850349690\">- Flow cytometry</a></li><li><a href=\"#H1839956429\" id=\"outline-link-H1839956429\">- Molecular/Genetic testing</a></li><li><a href=\"#H2981944586\" id=\"outline-link-H2981944586\">- Chromosome analysis</a></li></ul></li></ul></li><li><a href=\"#H330925166\" id=\"outline-link-H330925166\">LYMPHOCYTOPENIA</a><ul><li><a href=\"#H330925184\" id=\"outline-link-H330925184\">Causes and evaluation</a></li><li><a href=\"#H330925285\" id=\"outline-link-H330925285\">Management (lymphocytopenia)</a></li></ul></li><li><a href=\"#H330925315\" id=\"outline-link-H330925315\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#H4032127999\" id=\"outline-link-H4032127999\">ACKNOWLEDGMENT</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"HEME/104124|PIC\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"PICTURES\">PICTURES</a></div><ul><li><a href=\"image.htm?imageKey=HEME/55986\" class=\"graphic graphic_picture\">- Atypical lymphocytes</a></li><li><a href=\"image.htm?imageKey=HEME/115806\" class=\"graphic graphic_picture\">- Atypical lymphocytes pertussis</a></li><li><a href=\"image.htm?imageKey=HEME/116325\" class=\"graphic graphic_picture\">- Persistent polyclonal B lymphocytosis</a></li><li><a href=\"image.htm?imageKey=HEME/69027\" class=\"graphic graphic_picture\">- Large granular lymphocytes</a></li><li><a href=\"image.htm?imageKey=HEME/96498\" class=\"graphic graphic_picture\">- CLL peripheral smear</a></li><li><a href=\"image.htm?imageKey=HEME/65474\" class=\"graphic graphic_picture\">- Lymphoblasts in ALL</a></li><li><a href=\"image.htm?imageKey=HEME/54469\" class=\"graphic graphic_picture\">- CLL smear</a></li><li><a href=\"image.htm?imageKey=HEME/59065\" class=\"graphic graphic_picture\">- Villous lymphocytes of SMZL</a></li><li><a href=\"image.htm?imageKey=HEME/102936\" class=\"graphic graphic_picture\">- HCL peripheral blood</a></li><li><a href=\"image.htm?imageKey=HEME/65023\" class=\"graphic graphic_picture\">- FL with leukemic cells</a></li><li><a href=\"image.htm?imageKey=HEME/70592\" class=\"graphic graphic_picture\">- Mycosis fungoides blood</a></li><li><a href=\"image.htm?imageKey=HEME/57831\" class=\"graphic graphic_picture\">- ALL lymphoblasts in peripheral blood</a></li><li><a href=\"image.htm?imageKey=HEME/57366\" class=\"graphic graphic_picture\">- Burkitt lymphoma</a></li></ul></li><li><div id=\"HEME/104124|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=DERM/86760\" class=\"graphic graphic_table\">- Drugs associated with DRESS</a></li><li><a href=\"image.htm?imageKey=HEME/103750\" class=\"graphic graphic_table\">- Criteria for MBL</a></li><li><a href=\"image.htm?imageKey=HEME/58246\" class=\"graphic graphic_table\">- Causes of reactive lymphocytosis</a></li><li><a href=\"image.htm?imageKey=HEME/58469\" class=\"graphic graphic_table\">- Causes of lymphocytopenia</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=anemia-of-chronic-disease-inflammation\" class=\"medical medical_review\">Anemia of chronic disease/inflammation</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=approach-to-the-adult-with-anemia\" class=\"medical medical_review\">Approach to the adult with anemia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=approach-to-the-child-with-lymphocytosis-or-lymphocytopenia\" class=\"medical medical_review\">Approach to the child with lymphocytosis or lymphocytopenia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=approach-to-the-patient-with-neutrophilia\" class=\"medical medical_review\">Approach to the patient with neutrophilia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-features-and-diagnosis-of-hairy-cell-leukemia\" class=\"medical medical_review\">Clinical features and diagnosis of hairy cell leukemia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-pathologic-features-and-diagnosis-of-t-cell-large-granular-lymphocyte-leukemia\" class=\"medical medical_review\">Clinical manifestations, pathologic features, and diagnosis of T cell large granular lymphocyte leukemia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-pathologic-features-and-diagnosis-of-mantle-cell-lymphoma\" class=\"medical medical_review\">Clinical manifestations, pathologic features, and diagnosis of mantle cell lymphoma</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-pathologic-features-and-diagnosis-of-mycosis-fungoides\" class=\"medical medical_review\">Clinical manifestations, pathologic features, and diagnosis of mycosis fungoides</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-pathologic-features-and-diagnosis-of-peripheral-t-cell-lymphoma-not-otherwise-specified\" class=\"medical medical_review\">Clinical manifestations, pathologic features, and diagnosis of peripheral T cell lymphoma, not otherwise specified</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-pathologic-features-and-diagnosis-of-precursor-b-cell-acute-lymphoblastic-leukemia-lymphoma\" class=\"medical medical_review\">Clinical manifestations, pathologic features, and diagnosis of precursor B cell acute lymphoblastic leukemia/lymphoma</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-pathologic-features-and-diagnosis-of-precursor-t-cell-acute-lymphoblastic-leukemia-lymphoma\" class=\"medical medical_review\">Clinical manifestations, pathologic features, and diagnosis of precursor T cell acute lymphoblastic leukemia/lymphoma</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-pathologic-features-and-diagnosis-of-small-lymphocytic-lymphoma\" class=\"medical medical_review\">Clinical manifestations, pathologic features, and diagnosis of small lymphocytic lymphoma</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-pathologic-features-diagnosis-and-prognosis-of-follicular-lymphoma\" class=\"medical medical_review\">Clinical manifestations, pathologic features, diagnosis, and prognosis of follicular lymphoma</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-presentation-and-diagnosis-of-non-hodgkin-lymphoma\" class=\"medical medical_review\">Clinical presentation and diagnosis of non-Hodgkin lymphoma</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-presentation-and-management-of-thymoma-and-thymic-carcinoma\" class=\"medical medical_review\">Clinical presentation and management of thymoma and thymic carcinoma</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-presentation-pathologic-features-and-diagnosis-of-sezary-syndrome\" class=\"medical medical_review\">Clinical presentation, pathologic features, and diagnosis of S&eacute;zary syndrome</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-presentation-pathologic-features-diagnosis-and-differential-diagnosis-of-chronic-lymphocytic-leukemia\" class=\"medical medical_review\">Clinical presentation, pathologic features, diagnosis, and differential diagnosis of chronic lymphocytic leukemia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=combined-immunodeficiencies\" class=\"medical medical_review\">Combined immunodeficiencies</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=cytogenetics-and-molecular-genetics-in-acute-lymphoblastic-leukemia\" class=\"medical medical_review\">Cytogenetics and molecular genetics in acute lymphoblastic leukemia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=detection-of-minimal-residual-disease-in-acute-lymphoblastic-leukemia\" class=\"medical medical_review\">Detection of minimal residual disease in acute lymphoblastic leukemia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=donor-selection-for-hematopoietic-cell-transplantation\" class=\"medical medical_review\">Donor selection for hematopoietic cell transplantation</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=drug-allergy-classification-and-clinical-features\" class=\"medical medical_review\">Drug allergy: Classification and clinical features</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=drug-reaction-with-eosinophilia-and-systemic-symptoms-dress\" class=\"medical medical_review\">Drug reaction with eosinophilia and systemic symptoms (DRESS)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=epidemiology-clinical-manifestations-pathologic-features-and-diagnosis-of-burkitt-lymphoma\" class=\"medical medical_review\">Epidemiology, clinical manifestations, pathologic features, and diagnosis of Burkitt lymphoma</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=epidemiology-clinical-manifestations-pathologic-features-and-diagnosis-of-diffuse-large-b-cell-lymphoma\" class=\"medical medical_review\">Epidemiology, clinical manifestations, pathologic features, and diagnosis of diffuse large B cell lymphoma</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=flow-cytometry-for-the-diagnosis-of-primary-immunodeficiencies\" class=\"medical medical_review\">Flow cytometry for the diagnosis of primary immunodeficiencies</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=general-aspects-of-cytogenetic-analysis-in-hematologic-malignancies\" class=\"medical medical_review\">General aspects of cytogenetic analysis in hematologic malignancies</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=genetic-testing\" class=\"medical medical_review\">Genetic testing</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=hematopoietic-cell-transplantation-for-primary-immunodeficiency\" class=\"medical medical_review\">Hematopoietic cell transplantation for primary immunodeficiency</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=immune-globulin-therapy-in-primary-immunodeficiency\" class=\"medical medical_review\">Immune globulin therapy in primary immunodeficiency</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=infectious-mononucleosis-in-adults-and-adolescents\" class=\"medical medical_review\">Infectious mononucleosis in adults and adolescents</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=laboratory-evaluation-of-the-immune-system\" class=\"medical medical_review\">Laboratory evaluation of the immune system</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=microbiology-epidemiology-clinical-manifestations-and-diagnosis-of-cat-scratch-disease\" class=\"medical medical_review\">Microbiology, epidemiology, clinical manifestations, and diagnosis of cat scratch disease</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=natural-killer-nk-cell-large-granular-lymphocyte-leukemia\" class=\"medical medical_review\">Natural killer (NK) cell large granular lymphocyte leukemia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=normal-b-and-t-lymphocyte-development\" class=\"medical medical_review\">Normal B and T lymphocyte development</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pertussis-infection-in-adolescents-and-adults-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Pertussis infection in adolescents and adults: Clinical manifestations and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=primary-humoral-immunodeficiencies-an-overview\" class=\"medical medical_review\">Primary humoral immunodeficiencies: An overview</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=severe-combined-immunodeficiency-scid-an-overview\" class=\"medical medical_review\">Severe combined immunodeficiency (SCID): An overview</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=splenic-marginal-zone-lymphoma\" class=\"medical medical_review\">Splenic marginal zone lymphoma</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=tools-for-genetics-and-genomics-cytogenetics-and-molecular-genetics\" class=\"medical medical_review\">Tools for genetics and genomics: Cytogenetics and molecular genetics</a></li></ul></div></div>","javascript":null}